Sebelipase alfa – July 2026

  • Brand names:
    • Kanuma®
  • Pharmaceutical Company:
    • ALEXION PHARMACEUTICALS PTY LIMITED
  • Condition/Indication: Late-onset lysosomal acid lipase deficiency (LAL-D)
  • Meeting Date: July 2026
Public Summary Documents
Last updated
13 November 2026